Ovarian cancer is one of the most lethal malignant gynecological tumors. More than 70% of
patients with ovarian cancer are diagnosed at advanced stage. The 5-year survival in …

Ovarian cancer (OC) is often diagnosed at an advanced stage because of the late onset of
symptoms, and this together with the lack of effective treatments, has meant it is associated …

Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …

Objective MicroRNA (miRNA) is an abundant class of small noncoding RNAs that act as
gene regulators. Recent studies have suggested that miRNA deregulation is associated with …

Ovarian cancer is the leading cause of death among gynecologic malignancies and despite
advances in treatment, more than 50% of all patients will experience recurrence, resulting in …

Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …

MicroRNA (miRNA) is an abundant class of small non-coding RNAs that act as gene
regulators. Recent studies have suggested that miRNA deregulation is associated with the …

Ovarian cancer is the most lethal of malignant gynecological tumors. Its lethality may be due
to difficulties in detecting it at an early stage and lack of effective treatments for patients with …

Introduction: Ovarian cancer (OC) is the second most common and the most lethal of the
gynecological malignancies. Currently, there exists no effective screening tool for OC …

Ovarian cancer is the major cause of gynecologic cancer-related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …